// App-Quantinova.ai

e12571 : Identification of high risk basal like TNBC by an immunohistochemical approach.

Researchers

Presenter

  • Shilin N Shukla

Principal Investigators

  • Hemangini H Vora

  • Sonia K. Parikh

Medical Centers

  • Gujrat Cancer Research Institute, Ahmedabad, India

  • Gujrat Cancer Research Institute, Ahmedabad, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Cytokeratin 14

  • Cytokeratin 17

  • Cytokeratin 5

  • Epidermal growth factor receptor

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

  • Vimentin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved